<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · Regeneron</title><link>https://yestino.com/entities/regeneron-d5491e</link><description>Every event involving Regeneron</description><language>en</language><atom:link href="https://yestino.com/entities/regeneron-d5491e/feed.xml" rel="self" type="application/rss+xml"/><item><title>Sanofi is paying Regeneron up to $8 billion to expand their immunology alliance</title><link>https://yestino.com/events/sanofi-is-paying-regeneron-up-to-8-billion-to-expand-their-i-32cf61</link><guid isPermaLink="true">https://yestino.com/events/sanofi-is-paying-regeneron-up-to-8-billion-to-expand-their-i-32cf61</guid><pubDate>Fri, 02 Oct 2026 12:26:59 GMT</pubDate><description>Regeneron will receive $1 billion upfront, with up to $7 billion more in milestones, to co-develop four next-generation antibody drug candidates
Sources: Quartz</description></item></channel></rss>